DIA Biosimilars 2013

Technology Solutions

Genstar Capital to acquire ERT

Tuesday, April 10, 2012 11:24 AM

Philadelphia-based eResearch Technology, a technology-driven provider of health outcomes research services to sponsors and CROs, has agreed to be acquired by affiliates of Genstar Capital, a middle market private equity firm, for $8 per share in cash in a transaction valued at approximately $400 million.

More... »

Cenduit: Now with Patient Reminders

UL acquires EduNeering

Tuesday, April 10, 2012 06:30 AM

Global safety science company UL has acquired EduNeering, a provider of compliance and training solutions for the life and health sciences sector, from educational and career service Kaplan.

More... »

CRF Health – eCOA Forum

Mytrus rolls out informed consent iPad app

Monday, April 9, 2012 04:44 PM

Mytrus, a San Francisco-based clinical technology and services company, has launched an iPad application explaining informed consent prior to clinical trial patient enrollment.  

More... »

FDA approves Lilly’s Amyvid to detect Alzheimer's

Monday, April 9, 2012 11:53 AM

The FDA has approved Amyvid, a radioactive diagnostic agent indicated for brain imaging of beta-amyloid plaques associated with Alzheimer’s Disease and other cognitive decline, according to Eli Lilly and Avid Radiopharmaceuticals, a wholly owned subsidiary of Lilly.

More... »

U.K. launches clinical research datalink to improve research

Wednesday, April 4, 2012 11:54 AM

Clinical Practice Research Datalink (CPRD), an e-health secure research service, launched April 3, promising to help improve public health, quicken the development of new treatments for patients and attract investment in the U.K.’s life sciences sector and economy.

More... »

1000 Genomes Project data available on Amazon Cloud

Monday, April 2, 2012 02:51 PM

The world's largest set of data on human genetic variation — produced by the international 1000 Genomes Project — is now publicly available on the Amazon Web Services (AWS) cloud, the according to the National Institutes of Health (NIH).

More... »

BioClinica, Mirada partner for molecular image analysis

Monday, April 2, 2012 06:35 AM

Through a newly formed partnership, BioClinica, a global provider of clinical trial management solutions, will integrate Oxford-based Mirada Medical's XD3 software solution into its imaging core lab technology to enhance its PET capabilities and expertise for molecular imaging trials.

More... »

Quintiles to incorporate Archimedes’ healthcare simulator

Friday, March 30, 2012 02:19 PM

Quintiles and Archimedes, a healthcare modeling organization based in San Francisco, Calif., have formed an agreement to co-promote clinical and commercial solutions for biopharmaceutical companies to help reduce the time and expense associated with developing and marketing novel therapies.

More... »

King’s Health accelerates personalized cancer care with IDBS platform

Friday, March 30, 2012 12:10 PM

U.K.-based King’s Health Partners has deployed the Oncology Research Information System (ORIS), an enterprise translational medicine platform provided by IDBS.

More... »

Oracle acquires ClearTrial

Friday, March 30, 2012 11:22 AM

Oracle has entered into an agreement to acquire ClearTrial, a well-known provider of cloud-based Clinical Trial Operations (CTO) applications.

More... »

CenterWatch
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs